Clinical trial
Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute…
NCT00412802 · French Cardiology Society, Other · Completed
Key facts
| NCT number | NCT00412802 |
|---|---|
| Title | Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome |
| Official title | Validation of Enoxaparin Dose Adaptation in Patients With Moderate Renal Failure Hospitalized for an Acute Coronary Syndrome, the VALIDE Study |
| Lead sponsor | French Cardiology Society, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Coronary Syndrome, Renal Failure |
| Intervention type | Drug |
| Interventions | dose adaptation of Enoxaparin, normal injection of Enoxaparine |
| Enrollment | 67 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Dec 18, 2006 |
| Last update posted | Jul 21, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: